Navigation Links
Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
Date:7/21/2009

LAUSANNE, Switzerland, July 21 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced that the Swiss agency for therapeutic products, Swissmedic, has issued a marketing authorisation for Moapar(R) 11.25mg, the first 3-month injectable formulation, prescribed for a reversible reduction of serum testosterone to the level of castration in adult men suffering from sexual deviations. Developed by Debiopharm, Moapar(R) contains a gonadotropin-releasing hormone (GnRH) agonist analogue.

"We are very pleased that Swissmedic has recognised the potential of treatment of sexual deviations with Moapar(R)," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "This is an important signal for us, as we move closer to providing an alternative treatment for this controversial disorder. It's a small market, but we feel that it's our duty to make this treatment available to the medical profession."

Debiopharm already received marketing authorisations and signed license agreements for the distribution of Salvacyl(R)/Moapar(R) in nine major European countries, including France, Germany, the United Kingdom, Sweden, Norway, Denmark, Belgium, the Netherlands and Finland. The product was launched earlier this year in Germany and Belgium. Initial contacts with potential distribution partners for the Swiss market have been made.

About Moapar(R)

In the treatment of sexual deviations in men, intra-muscular administration of Moapar(R) every 3 months, in combination with psychotherapy, presents an advantage over daily oral forms or intra-muscular weekly injections required with antiandrogens such as cyproterone acetate (CPA) and medroxyprogesterone acetate (MPA), and there are fewer side effects.

The approval is based on two s
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA
2. Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
3. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
4. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
5. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
6. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
7. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
8. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
9. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
10. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
11. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
(Date:8/27/2015)... Biosimilars are not generics and the ... and Drug Administration (FDA) for recognizing that each ... guidance issued today. The FDA,s draft guidance on ... calling for biological products to bear a nonproprietary ... reflects the agency,s thinking that "there is a ...
(Date:8/27/2015)... According to a new market research report "Medical Lifting ... ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End User ... Medical Lifting Sling Market is poised to reach USD 706.0 Million ... of 11.4 % from 2015 to 2020. , ... ables and 65 F igures ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Bermuda, Dec. 16 Celtic Pharmaceutical Holdings L.P. ("Celtic ... preliminary analyses completed on the two double-blinded studies of XERECEPT ... edema, as well as an initial database lock on the ... , The results of these studies ...
... Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time ... MannKind Corporation (Nasdaq: MNKD ) will host ... 3 studies of AFRESA(TM), the company,s ultra rapid acting, inhaled insulin product, ... , , To participate in the live ...
Cached Medicine Technology:Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... specialist, Dr. James Strawbridge, gives a new approach on solutions in his new ... with the employer and employees getting together for meaningful group meetings. "This would ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... ... , ... The Quatela Center for Plastic Surgery is excited to bring patients ... approved by the Food and Drug Administration to eliminate submental fat, also known as ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     ...
(Date:8/28/2015)... ... August 28, 2015 , ... SharkNinja, an innovative leader ... and Emmy-nominated actress, Sofia Vergara, and unveil the Ninja® brand’s new coffee ... which delivers a variety of sizes and styles while achieving the perfect brew ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... TCS Founder Pock Presents Gift to CMSA Foundation President ... AUBURN, Calif., July 16 TCS Healthcare Technologies (TCS), ... an unrestricted grant of $5,000 to the Case Management Society of America ... , , Rob Pock, TCS ...
... HOFFMAN ESTATES, Ill., July 16 St. Alexius Medical Center, Hoffman Estates, ... annual America,s Best Hospitals list published by U.S. News ... ranked among the top 50 hospitals in the nation for the treatment ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ) , , ...
... Calif., July 16 MO BIO Laboratories, Inc., the ... of an innovative new product, PowerFood(TM) Microbial DNA Isolation Kit, designed ... , The PowerFood Microbial DNA Isolation Kit ... that allows for isolation of DNA from a variety of gram ...
... , , PALO ALTO, Calif., July ... been elected chairman of the company,s Board of Directors. , ... biotechnology industry, and as the former chairman of Connetics Corporation and ... and success to TOPICA, as well as an exceptional knowledge of ...
... , , CHICAGO, July 16 ... provides health care services for those needing sub-acute medical and ... its board of directors has named Dale Zaletel as the ... Zaletel, who previously held the position of Chief Operating Officer ...
... , , Gamers Engage ... NEW YORK, July 16 /PRNewswire-USNewswire/ -- The MS ... sclerosis (MS) to exercise their brain power. The Collaborative, an alliance ... announced the launch of MyBrainGames, a free suite of online cognitive games ...
Cached Medicine News:Health News:TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation 2Health News:TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation 3Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:MO BIO Laboratories, Inc. Launches PowerFood(TM) Microbial DNA Isolation Kit 2Health News:TOPICA Elects G. Kirk Raab as Chairman of the Board 2Health News:Lexington Health Care Names New Chief Executive Officer 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 3Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 4
... Are Turned 90 Degrees To Allow ... While Incising Tissue. ,Special Mirror-Polished Double Footplate ... Blade Extension Settings Of 0.5mm, 0.55mm, ... Extension.,1mm Wide Snub Nose Diamond Blade ...
... Unique In-Line Footplates Are Turned ... Of The Diamond Blade While Incising ... Precise Blade Depth Penetration.,Pre-Set Blade Extension ... Full Retraction And Full Extension.,1mm Wide ...
... 23g Tube Allows Use Through A ... More Comfortable Approach To The Incision.,Cystotome ... Capsule To Initiate And Complete A ... Weight For Improved Ergonomic Feel. Ideal ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Medicine Products: